November 28, 2021

Multiple myeloma treatment has improved significantly in recent years. However, mortality early in the course of the disease is still common. This study focuses on discovering trends in early mortality. The researchers sought to better understand demographic and socioeconomic factors associated with early mortality, which can then be used to better target resources for those...

In this MD Newsline exclusive interview with Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office, we discuss the safety of the COVID-19 vaccines, and where to turn to learn more about vaccine safety. MD Newsline: What have you learned about the safety of the COVID-19 vaccines? Dr. Tom Shimabukuro: “We know a lot about...

In this MD Newsline exclusive interview with Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office, we discuss the CDC’s/FDA’s Vaccine Adverse Event Reporting System. MD Newsline: Some people are confused about how to interpret reports sent to the Vaccine Adverse Event Reporting System (VAERS). Could you elaborate on how VAERS works and how to...

In this MD Newsline exclusive interview with Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office, we discuss how the CDC monitors vaccine safety. MD Newsline: How does the CDC monitor vaccine safety? Dr. Tom Shimabukuro: “At the CDC, we have several systems that help us monitor the safety of vaccines. The first system is...

In this MD Newsline exclusive interview with Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office, we discuss why the CDC monitors vaccine safety. MD Newsline: Why does the CDC monitor the safety of vaccines once they have been authorized or licensed by the FDA?  Dr. Tom Shimabukuro: “The standards for vaccine safety are quite...